Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?

Journal Article (Journal Article;Review)

Cardio-oncology is an emerging field tasked with identifying and treating cancer therapy related cardiac dysfunction (e.g., cytotoxic agents, immunotherapies, radiation, and hormone therapies) and optimizing the cardiovascular health of cancer patients exposed to these agents. Novel cancer therapies have led to significant improvements in clinical outcomes for breast cancer patients. In this article, we review the current literature on assessing cardiovascular risk of breast cancer therapies and discuss strategies (including pharmacological and lifestyle interventions) to prevent cardiovascular toxicity.

Full Text

Duke Authors

Cited Authors

  • Kikuchi, R; Shah, NP; Dent, SF

Published Date

  • March 25, 2020

Published In

Volume / Issue

  • 9 / 4

PubMed ID

  • 32218132

Pubmed Central ID

  • PMC7230166

International Standard Serial Number (ISSN)

  • 2077-0383

Digital Object Identifier (DOI)

  • 10.3390/jcm9040896


  • eng

Conference Location

  • Switzerland